Published in Cancer Cell on January 01, 2007
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle (2009) 3.55
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev (2009) 2.58
Targeting Notch to target cancer stem cells. Clin Cancer Res (2010) 2.46
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun (2013) 1.61
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med (2007) 1.48
Migration rules: tumours are conglomerates of self-metastases. Br J Cancer (2009) 1.48
Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells. PLoS One (2015) 1.44
The biology of head and neck cancer stem cells. Oral Oncol (2011) 1.25
Brain cancer propagating cells: biology, genetics and targeted therapies. Trends Mol Med (2009) 1.23
Oncolytic viral therapy: targeting cancer stem cells. Oncolytic Virother (2014) 1.11
The difficulty of targeting cancer stem cell niches. Clin Cancer Res (2010) 1.08
Tumor initiating cells in malignant gliomas: biology and implications for therapy. J Mol Med (Berl) (2009) 1.01
Cancer stem cell and stromal microenvironment. Ochsner J (2013) 0.98
Predicting the future for people with lung cancer. Nat Med (2008) 0.97
Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells. Oncotarget (2016) 0.97
Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. J Cell Mol Med (2009) 0.95
Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) (2008) 0.95
The H(+) vacuolar ATPase maintains neural stem cells in the developing mouse cortex. Stem Cells Dev (2011) 0.95
Targeting pediatric cancer stem cells with oncolytic virotherapy. Pediatr Res (2012) 0.92
Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma. Oncotarget (2015) 0.92
Gastric cancer stem cells: therapeutic targets. Gastric Cancer (2013) 0.88
Cancer stem cell theory: therapeutic implications for nanomedicine. Int J Nanomedicine (2013) 0.84
Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy. EBioMedicine (2017) 0.83
Oncogenesis and cancer stem cells: current opinions and future directions. J Cell Mol Med (2009) 0.78
Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature. Cancer Biol Ther (2014) 0.75
Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells. Front Pharmacol (2016) 0.75
Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells. Oncotarget (2016) 0.75
Cancer stem cells in prostate cancer. Transl Androl Urol (2013) 0.75
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell (2008) 5.06
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci (2005) 3.97
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell (2009) 3.11
Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development (2005) 2.97
Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A (2003) 2.72
An animal model of MYC-driven medulloblastoma. Cancer Cell (2012) 2.12
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma. Genes Dev (2009) 1.45
Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol Cell Biol (2006) 1.38
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J Neurobiol (2005) 1.26
Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells. Proc Natl Acad Sci U S A (2007) 1.24
Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci U S A (2007) 1.13
WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum. Development (2012) 1.12
CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma. Cancer Res (2011) 1.09
A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity. Nat Neurosci (2013) 1.04
Getting at the root and stem of brain tumors. Neuron (2004) 0.97
Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases. Cancer Res (2013) 0.92
Matching mice to malignancy: molecular subgroups and models of medulloblastoma. Childs Nerv Syst (2012) 0.83
Spheres without influence: dissociating in vitro self-renewal from tumorigenic potential in glioma. Cancer Cell (2012) 0.80
A malignant oligarchy: progenitors govern the behavior of oligodendrogliomas. Cancer Cell (2010) 0.79
Stem cells and the origin and propagation of brain tumors. J Child Neurol (2008) 0.79
Independently specified Atoh1 domains define novel developmental compartments in rhombomere 1. Development (2014) 0.75